What to Know About the CFO of Tempus AI's Latest Insider Transaction Filing
This non-discretionary sale to cover RSU withholding obligations reduced his direct stake, but he retains about 106,000 shares valued at $6.49 million.
James William Rogers, the CFO of Tempus AI, Inc. (TEM), executed a series of insider stock sales on August 18 and 19, as reported by the company's recent SEC Form 4 filing. In these transactions, Rogers divested 48,842 shares of Class A Common Stock, generating a transaction value of $2.85 million based on the weighted average sale price of $55.21 per share. However, the value of his holdings increased post-trade to $3.76 million, calculated using the August 19 market close price of $61.25 per share.
Tempus AI, a leading healthcare technology firm based in Chicago, currently employs around 3,800 individuals and has reached $1.4 billion in trailing twelve months (TTM) revenue. The company's unique value proposition resides in its proprietary multimodal data repository and seamless integration between clinical diagnostics and AI-powered analytics, which offers a comprehensive, full-stack solution in precision medicine.
Despite currently operating at a net loss of $254.4 million TTM, Tempus AI boasts a substantial market valuation of $10.7 billion. This valuation underscores investor confidence in the company's technological prowess and the vast market potential within healthcare information services.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
